Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 499 JPY 2.18% Market Closed
Market Cap: 86.1B JPY
Have any thoughts about
Kyorin Holdings Inc?
Write Note

Kyorin Holdings Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kyorin Holdings Inc
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Kyorin Holdings Inc
TSE:4569
Total Liabilities & Equity
ÂĄ178.9B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
1%
Takeda Pharmaceutical Co Ltd
TSE:4502
Total Liabilities & Equity
ÂĄ14.6T
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
12%
Daiichi Sankyo Co Ltd
TSE:4568
Total Liabilities & Equity
ÂĄ3.3T
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
6%
Otsuka Holdings Co Ltd
TSE:4578
Total Liabilities & Equity
ÂĄ3.6T
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Total Liabilities & Equity
ÂĄ1.9T
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
10%
Astellas Pharma Inc
TSE:4503
Total Liabilities & Equity
ÂĄ3.7T
CAGR 3-Years
18%
CAGR 5-Years
14%
CAGR 10-Years
9%
No Stocks Found

Kyorin Holdings Inc
Glance View

Market Cap
86.1B JPY
Industry
Pharmaceuticals

KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Intrinsic Value
2 168.03 JPY
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Kyorin Holdings Inc's Total Liabilities & Equity?
Total Liabilities & Equity
178.9B JPY

Based on the financial report for Sep 30, 2024, Kyorin Holdings Inc's Total Liabilities & Equity amounts to 178.9B JPY.

What is Kyorin Holdings Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
1%

Over the last year, the Total Liabilities & Equity growth was 2%. The average annual Total Liabilities & Equity growth rates for Kyorin Holdings Inc have been 3% over the past three years , 2% over the past five years , and 1% over the past ten years .

Back to Top